Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $42.11 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.